Clinical Trial Update: Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS) [Phase 2]

View source ↗

Summary

Phase II study of INCB024360 (epacadostat) in patients with myelodysplastic syndromes has completed and results were posted (January 2016).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• INCB024360 (epacadostat)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2016-01-18